483 Tianjin Tianyao Pharmaceuticals Sep 2016

483 Tianjin Tianyao Pharmaceuticals Sep 2016

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Tianjin Tianyao Pharmaceuticals - Tianjin, China facility and issued inspectional observations (via FDA 483) on 01 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Sep 2016
  • Location: Tianjin, China
  • FEI: 3007751421
Add To Cart